BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14670325)

  • 1. Co-immunization with an HIV-1 Tat transduction peptide-rotavirus enterotoxin fusion protein stimulates a Th1 mucosal immune response in mice.
    Kim TG; Befus N; Langridge WH
    Vaccine; 2004 Jan; 22(3-4):431-8. PubMed ID: 14670325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response.
    Choi NW; Estes MK; Langridge WH
    J Biotechnol; 2006 Jan; 121(2):272-83. PubMed ID: 16181698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis.
    Choi NW; Estes MK; Langridge WH
    Vaccine; 2005 Oct; 23(44):5168-76. PubMed ID: 16040169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
    Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
    Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato.
    Kim TG; Langridge WH
    Plant Cell Rep; 2004 Jan; 22(6):382-7. PubMed ID: 14551730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
    Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
    Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
    Iosef C; Chang KO; Azevedo MS; Saif LJ
    J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA.
    Marinaro M; Riccomi A; Rappuoli R; Pizza M; Fiorelli V; Tripiciano A; Cafaro A; Ensoli B; De Magistris MT
    Vaccine; 2003 Sep; 21(25-26):3972-81. PubMed ID: 12922133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules.
    Fraternale A; Paoletti MF; Dominici S; Buondelmonte C; Caputo A; Castaldello A; Tripiciano A; Cafaro A; Palamara AT; Sgarbanti R; Garaci E; Ensoli B; Magnani M
    Vaccine; 2011 Sep; 29(40):6823-9. PubMed ID: 21816192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.
    Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E
    J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat.
    Caselli E; Betti M; Grossi MP; Balboni PG; Rossi C; Boarini C; Cafaro A; Barbanti-Brodano G; Ensoli B; Caputo A
    J Immunol; 1999 May; 162(9):5631-8. PubMed ID: 10228047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
    Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
    J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato.
    Kim TG; Langridge WH
    Plant Cell Rep; 2003 Jun; 21(9):884-90. PubMed ID: 12789506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
    Lian T; Bui T; Ho RJ
    Vaccine; 1999 Nov; 18(7-8):604-11. PubMed ID: 10547418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses.
    Fanales-Belasio E; Moretti S; Nappi F; Barillari G; Micheletti F; Cafaro A; Ensoli B
    J Immunol; 2002 Jan; 168(1):197-206. PubMed ID: 11751963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice.
    Choi NW; Estes MK; Langridge WH
    Viral Immunol; 2006; 19(1):54-63. PubMed ID: 16553550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection.
    Richardson MW; Mirchandani J; Duong J; Grimaldo S; Kocieda V; Hendel H; Khalili K; Zagury JF; Rappaport J
    Biomed Pharmacother; 2003 Jan; 57(1):4-14. PubMed ID: 12642031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.